Back to top
more

Delaware Healthcare Fund Class A: (MF: DLHAX)

(NASDAQ Mutual Funds) As of Jul 19, 2018 08:15 PM ET

 Add to portfolio

$25.46 USD

0.00 (0.00%)

Zacks MF Rank 2-Buy   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jun 30, 2018

Total Return %* Percentile Rank Objective
YTD 9.87 17
3 months 8.70 13
6 months 9.87 17
1 Year 21.79 7
3 Year 10.18 7
5 Year 16.34 28
10 Year 19.08 2

* Annual for three years and beyond.

Zacks Premium Research for DLHAX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 23.31
% Yield 2.58
% SEC Yield
Net Assets (Mil $) 6/30/2018 256.11
%Turnover 6/30/2018 28.00

Risk

3 Year 5 Year 10 Year
Beta 1.16 0.98 0.95
Alpha -2.79 3.16 9.06
R Squared 0.69 0.56 0.68
Std. Dev. 14.07 12.88 16.99
Sharpe 0.74 1.30 1.00

Sector / Country Weightings

As of 6/30/2018 % of Portfolio
Health 56.22
Other 16.91
Finance 7.97
Industrial Cyclical 5.13
Services 4.43
Technology 3.80
Retail Trade 3.49
Non-Durable 2.05

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2018)
% of Portfolio Value (Mil$)
MORPHOSYS AG 7.52 43.39
CHUGAI PHARMACEUTICAL 5.26 30.34
ARENA PHARMACEUTICALS INC 3.21 18.53
PFIZER INC 3.07 17.75
SANOFI 2.99 17.25
SANOFI ADR 2.99 17.23
ELI LILLY & CO 2.82 16.25
UNITEDHEALTH GROUP INC 2.60 14.98
ZIMMER HOLDINGS INC 2.59 14.94

Stock Holding % of Net Assets

As Of 3/31/2018
Total Issues 74
Avg. P/E 29.85
Avg. P/Book 5.49
Avg. EPS Growth 15.05
Avg. Market Value (Mil $) 49,011

Allocation

% of Portfolio
Large Growth 10.75
Large Value 17.24
Small Growth 10.70
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 37.39
High Yield Bond 0.00